Sunday, November 16, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Wall Street Grows Wary of AMD’s AI Ambitions

Robert Sasse by Robert Sasse
November 16, 2025
in AI & Quantum Computing, Analysis, Semiconductors, Tech & Software
0
AMD Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

A significant shift in sentiment is underway among financial analysts covering Advanced Micro Devices. Once celebrated as a primary challenger to Nvidia in the explosive artificial intelligence chip sector, AMD now faces a wave of downgrades and sharply reduced price targets, casting doubt on its competitive standing.

A Cascade of Cautious Revisions

The reassessment of AMD’s prospects began in December 2024 and has intensified into the new year. On December 9, Bank of America set the tone by demoting the stock from “Buy” to “Neutral.” Analyst Vivek Arya simultaneously slashed the price objective from $180 to $155, citing intensified competitive pressures and a limited potential for AMD to capture meaningful market share from Nvidia’s AI dominance.

This was followed by a series of similar actions from other firms. Truist Securities reduced its price target to $155 a week later. A more severe warning came from Wolfe Research on December 17, which projected that 2025 revenues could fall roughly $3 billion short of expectations. The firm revised its AI revenue forecast for AMD down to $7 billion, labeling the company’s progress in the field as “weaker than anticipated.” Morgan Stanley added to the pessimism on December 20, lowering its price target from $169 to $158 and pointing to Nvidia’s formidable competitive strength as a major constraint on AMD’s growth.

HSBC Delivers a Severe Blow

The most dramatic move came from HSBC on January 8, 2025. The bank executed a rare double-downgrade, jumping directly from “Buy” to “Reduce.” In a brutal adjustment, its price target was cut by 45%, plummeting from $200 to $110. HSBC’s analysts described AMD’s AI chip roadmap as “less competitive than previously thought,” specifically highlighting weak demand for the MI325 accelerator and expressing skepticism about the upcoming MI350 chip.

Consequently, HSBC drastically lowered its 2025 AI GPU revenue forecast for AMD from $12.3 billion to $8.1 billion—a figure substantially below the analyst consensus of $9.5 billion. The bank identified a key reason: major cloud clients, including Amazon, are increasingly favoring their own proprietary chips or Nvidia’s products over solutions from AMD.

Should investors sell immediately? Or is it worth buying AMD?

The Nvidia Hurdle Proves Formidable

The central issue for AMD appears to be an inability to keep pace with Nvidia in the high-stakes AI race. While AMD maintains strong relationships with tech giants like Microsoft, Meta, and Oracle, evidence suggests these key customers are allocating the bulk of their investment budgets toward Nvidia’s premium Blackwell architecture. According to analyst reports, Amazon has been explicit about its preference for its own Trainium processors and Nvidia’s chips.

The market’s reaction has been clear. In December 2024 alone, AMD shares declined by 11.9%. For the full year 2024, the stock finished down approximately 18%, a performance that occurred despite the company posting strong quarterly results in October.

A Glimmer of Resilience Amid the Gloom

Despite the negative analyst momentum, AMD’s underlying business shows areas of strength. The company reported record revenue of $6.8 billion for the third quarter of 2024, representing an 18% year-over-year increase. Its Data Center segment was a particular standout, exploding with 122% growth to reach $3.5 billion, driven by robust sales of Instinct GPUs and EPYC server processors.

The overall analyst picture remains mixed. Out of 54 covering analysts, 44 still maintain “Buy” or “Strong Buy” ratings on the stock. However, the recent downgrades send an unambiguous signal that short-term expectations have been severely dampened. All eyes are now on the next quarterly report, due in late January. The results will be critical in determining whether AMD can successfully counter the growing skepticism or if its narrative as a failed challenger to Nvidia will become further entrenched.

Ad

AMD Stock: Buy or Sell?! New AMD Analysis from November 16 delivers the answer:

The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 16.

AMD: Buy or sell? Read more here...

Tags: AMD
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Apex Critical Metals Stock
Analysis

Apex Critical Metals: Major Niobium Discovery Signals Potential

November 16, 2025
Coca-Cola Stock
Analysis

Coca-Cola Executes Strategic Portfolio Shift with Landmark Bottler Divestment

November 16, 2025
Beyond Meat Stock
Analysis

Beyond Meat Shares Surge on Debt Conversion News

November 16, 2025
Next Post
Eli Lilly Stock

Eli Lilly's Multi-Billion Dollar Expansion Strategy

Fiserv Stock

Fiserv Shares Face Leadership Test Amid Crisis

Barrick Mining Stock

Barrick Gold Delivers Stellar Quarterly Performance

Recommended

Take-Two Stock

Take-Two Faces Internal Restructuring Amid Major Game Launches

2 months ago
Lockheed Stock

Defense Giant Lockheed Martin Secures Landmark $25 Billion in Contracts

2 months ago
Hexcel Stock

Mixed Signals Emerge for Hexcel as Major Investors Diverge

3 months ago
Travelzoo Stock

Travelzoo Stock: Major Investor Dumps Shares Amid Plunge

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Take-Two’s Strategic Delay: Short-Term Pain for Long-Term Gain?

Valero Energy Shares Surge to New Heights as Refining Giant Posts Stellar Results

Microchip Stock Seeks Momentum Amid Market Volatility

Europe’s Green Lithium Pioneer Powers Ahead with Major Milestones

Hims & Hers Stock: Profitability Concerns Overshadow Strong Revenue Growth

Nike at a Crossroads: Diverging Views on Sportswear Giant’s Future

Trending

Apex Critical Metals Stock
Analysis

Apex Critical Metals: Major Niobium Discovery Signals Potential

by Robert Sasse
November 16, 2025
0

Niobium stands among the world's most sought-after critical minerals, playing an indispensable role in high-strength steel alloys,...

Coca-Cola Stock

Coca-Cola Executes Strategic Portfolio Shift with Landmark Bottler Divestment

November 16, 2025
Beyond Meat Stock

Beyond Meat Shares Surge on Debt Conversion News

November 16, 2025
Take-Two Stock

Take-Two’s Strategic Delay: Short-Term Pain for Long-Term Gain?

November 16, 2025
Valero Energy Stock

Valero Energy Shares Surge to New Heights as Refining Giant Posts Stellar Results

November 16, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Apex Critical Metals: Major Niobium Discovery Signals Potential
  • Coca-Cola Executes Strategic Portfolio Shift with Landmark Bottler Divestment
  • Beyond Meat Shares Surge on Debt Conversion News

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com